^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Merkel Cell Carcinoma |
| Regimen: | EP (cisplatin + etoposide IV) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
10/02/2019
Excerpt:
Merkel Cell Carcinoma: Preferred regimen...Useful in certain circumstances as clinical judgment dictates for patients with contraindications to checkpoint immunotherapy...Cisplatin±Etoposide
